Erzofri is an atypical antipsychotic that is administered once a month as an intramuscular injection by a health care professional.

Agitated patients are often prescribed antipsychotic medications and sedatives off-label, but this can pose a risk to the ...

The purpose of black box warnings is to draw immediate attention to the most serious potential adverse effects of a drug, ...

Luye Pharma Group today announced that ERZOFRI® extended-release injectable suspension is now available for commercial sale ...

More than 92% of schizophrenia patients taking Olanzapine LAI in the Phase 3 SOLARIS survey were satisfied or very satisfied with the initiation regimen, dosing schedule and trial medication 1. These ...

Vanda Pharmaceuticals Inc. (Vanda) today announced that a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) requesting marketing approval of Bysantitm ...

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S.

The company’s product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for ...

Antipsychotic drugs are the primary treatment for psychotic disorders. These medications can reduce psychosis symptoms in people with mental health conditions such as schizophrenia. However ...

References [1] Rajagopalan K, Wade S, Meyer N et al. Real-world adherence assessment of lurasidone and other oral atypical antipsychotics among patients with schizophrenia: an administrative ...

Chronic inflammation increases the risk of serious health conditions. If you experience signs of inflammation—whether common or atypical—talk to your healthcare provider about getting bloodwork to ...